Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$419K Buy
1,158
+52
+5% +$17.8K 0.32% 119
2026
Q1
$389K Buy
1,106
+14
+1% +$4.99K 0.33% 122
2025
Q4
$357K Sell
1,092
-810
-43% -$257K 0.32% 133
2025
Q3
$537K Buy
1,902
+864
+83% +$251K 0.48% 73
2025
Q2
$290K Buy
1,038
+9
+0.9% +$2.55K 0.27% 149
2025
Q1
$321K Buy
1,029
+48
+5% +$14.2K 0.32% 138
2024
Q4
$256K Buy
+981
New +$291K 0.25% 165

Other funds holding AMGN

Severin Investments's AMGN Position: Q2 2026 in Review

Severin Investments increased its Amgen (AMGN) stake by 4.7% in Q2 2026, buying an estimated $17.8K and bringing the position to 1,158 shares worth $419K. The position accounts for 0.32% of the portfolio, ranked #119.

Severin Investments first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $537K in Q3 2025. 3,133 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Severin Investments held 1,158 shares of Amgen worth $419K as of Q2 2026.
  • Severin Investments bought 52 Amgen shares in Q2 2026, an estimated $17.8K.
  • Amgen made up 0.32% of Severin Investments's portfolio in Q2 2026, its #119 holding.
  • Severin Investments first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • Severin Investments's Amgen position peaked at $537K in Q3 2025.
  • 3,133 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Severin Investments's 13F filing for Q2 2026, filed 14 Aug 2026.